Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK0429 in postmenopausal osteoporosis
NCT00533650Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Dec 2000
- Primary completion
- Oct 2002
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of MK-0429 in osteoporosis, sponsored by Merck & Co.. Started Dec 2000; status: completed.
02
Drugs
MK-0429
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00533650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00533650.